Emerald Acquisition’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$43K Sell
712
-6,476
-90% -$391K ﹤0.01% 2896
2016
Q2
$473K Buy
+7,188
New +$473K ﹤0.01% 2488